Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Oct;116(4):2183–2190. doi: 10.1111/j.1476-5381.1995.tb15052.x

Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.

B K Kemp 1, T M Cocks 1
PMCID: PMC1908960  PMID: 8564247

Abstract

1. The aim of this study was to investigate the mechanism of enhanced reactivity to 5'-hydroxytryptamine (5-HT) and sumatriptan previously observed in human isolated coronary arteries when active force was raised with the thromboxane A2-mimetic, U46619. 2. Ring segments of dog isolated coronary artery and saphenous vein were suspended in organ baths and cumulative concentration-contraction curves to 5-HT, sumatriptan and methysergide were constructed in the absence and presence of low concentrations of U46619. 3. In both endothelium-intact and endothelium-denuded rings of coronary artery, precontraction with U46619 to low (< 10% Fmax; the contraction to a maximum depolarizing 125 mM KCl Krebs solution; KPSS) levels of active force had no effect on either the maximum contraction or sensitivity (pEC50) to 5-HT, sumatriptan and methysergide. 4. Ketanserin (1 microM) had no effect on contractions to sumatriptan and methysergide in endothelium-denuded coronary artery rings, but reduced the maximum contraction to 5-HT by approximately 90% to a value (5% Fmax) similar to that for sumatriptan and methylsergide. Under these conditions, U46619 precontraction had no effect on either pEC50 or maximum for 5-HT, sumatriptan or methysergide. 5. In rings of saphenous vein with endothelium and treated with ketanserin (1 microM), 5-HT and sumatriptan caused equal maximum responses of 65% Fmax which were approximately double that of methysergide (32% Fmax). The maximum responses and sensitivity to 5-HT, sumatriptan, methysergide and noradrenaline were unaffected by precontraction with U46619.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
2183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus J. A., Cocks T. M., Satoh K. Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol. 1986 Aug;88(4):767–777. doi: 10.1111/j.1476-5381.1986.tb16249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Apperley E., Feniuk W., Humphrey P. P., Levy G. P. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol. 1980 Feb;68(2):215–224. doi: 10.1111/j.1476-5381.1980.tb10410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chester A. H., Martin G. R., Bodelsson M., Arneklo-Nobin B., Tadjkarimi S., Tornebrandt K., Yacoub M. H. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res. 1990 Nov;24(11):932–937. doi: 10.1093/cvr/24.11.932. [DOI] [PubMed] [Google Scholar]
  4. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  5. Cocks T. M., Kemp B. K., Pruneau D., Angus J. A. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Br J Pharmacol. 1993 Sep;110(1):360–368. doi: 10.1111/j.1476-5381.1993.tb13818.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen R. A. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade. J Pharmacol Exp Ther. 1986 May;237(2):548–552. [PubMed] [Google Scholar]
  7. Connor H. E., Feniuk W., Humphrey P. P. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol. 1989 Feb 14;161(1):91–94. doi: 10.1016/0014-2999(89)90184-2. [DOI] [PubMed] [Google Scholar]
  8. Feniuk W., Humphrey P. P., Perren M. J., Watts A. D. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol. 1985 Nov;86(3):697–704. doi: 10.1111/j.1476-5381.1985.tb08948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frenken M., Kaumann A. J. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):301–303. doi: 10.1007/BF00515557. [DOI] [PubMed] [Google Scholar]
  10. Golino P., Ashton J. H., Buja L. M., Rosolowsky M., Taylor A. L., McNatt J., Campbell W. B., Willerson J. T. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Circulation. 1989 Jan;79(1):154–166. doi: 10.1161/01.cir.79.1.154. [DOI] [PubMed] [Google Scholar]
  11. Golino P., Maseri A. Serotonin receptors in human coronary arteries. Circulation. 1994 Sep;90(3):1573–1575. doi: 10.1161/01.cir.90.3.1573. [DOI] [PubMed] [Google Scholar]
  12. Golino P., Piscione F., Willerson J. T., Cappelli-Bigazzi M., Focaccio A., Villari B., Indolfi C., Russolillo E., Condorelli M., Chiariello M. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 1991 Mar 7;324(10):641–648. doi: 10.1056/NEJM199103073241001. [DOI] [PubMed] [Google Scholar]
  13. He G. W., Angus J. A., Rosenfeldt F. L. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol. 1988 Jul;12(1):12–22. doi: 10.1097/00005344-198807000-00003. [DOI] [PubMed] [Google Scholar]
  14. Humphrey P. P., Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci. 1991 Dec;12(12):444–446. doi: 10.1016/0165-6147(91)90630-b. [DOI] [PubMed] [Google Scholar]
  15. Humphrey P. P., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates L. H., Butina D. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988 Aug;94(4):1123–1132. doi: 10.1111/j.1476-5381.1988.tb11630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kaumann A. J., Frenken M., Posival H., Brown A. M. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors. Circulation. 1994 Sep;90(3):1141–1153. doi: 10.1161/01.cir.90.3.1141. [DOI] [PubMed] [Google Scholar]
  17. MacLennan S. J., Martin G. R. Effect of the thromboxane A2-mimetic U46619 on 5-HT1-like and 5-HT2 receptor-mediated contraction of the rabbit isolated femoral artery. Br J Pharmacol. 1992 Oct;107(2):418–421. doi: 10.1111/j.1476-5381.1992.tb12761.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McFadden E. P., Bauters C., Lablanche J. M., Leroy F., Clarke J. G., Henry M., Schandrin C., Davies G. J., Maseri A., Bertrand M. E. Effect of ketanserin on proximal and distal coronary constrictor responses to intracoronary infusion of serotonin in patients with stable angina, patients with variant angina, and control patients. Circulation. 1992 Jul;86(1):187–195. doi: 10.1161/01.cir.86.1.187. [DOI] [PubMed] [Google Scholar]
  19. McFadden E. P., Clarke J. G., Davies G. J., Kaski J. C., Haider A. W., Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med. 1991 Mar 7;324(10):648–654. doi: 10.1056/NEJM199103073241002. [DOI] [PubMed] [Google Scholar]
  20. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  21. Mullane K. M., Bradley G., Moncada S. The interactions of platelet-derived mediators on isolated canine coronary arteries. Eur J Pharmacol. 1982 Oct 15;84(1-2):115–118. doi: 10.1016/0014-2999(82)90166-2. [DOI] [PubMed] [Google Scholar]
  22. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
  23. Nakashima A., Angus J. A., Johnston C. I. Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol. 1982 Jul 16;81(3):487–492. doi: 10.1016/0014-2999(82)90114-5. [DOI] [PubMed] [Google Scholar]
  24. Paiva M. Q., Caramona M. M., Osswald W. The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):616–622. doi: 10.1007/BF00165625. [DOI] [PubMed] [Google Scholar]
  25. Perrin V. L., Färkkilä M., Goasguen J., Doenicke A., Brand J., Tfelt-Hansen P. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia. 1989;9 (Suppl 9):63–72. doi: 10.1111/J.1468-2982.1989.TB00075.X. [DOI] [PubMed] [Google Scholar]
  26. Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. N Engl J Med. 1991 Aug 1;325(5):316–321. doi: 10.1056/NEJM199108013250504. [DOI] [PubMed] [Google Scholar]
  27. Willett F., Curzen N., Adams J., Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. BMJ. 1992 May 30;304(6839):1415–1415. doi: 10.1136/bmj.304.6839.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zeiher A. M., Schächinger V., Weitzel S. H., Wollschläger H., Just H. Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Circulation. 1991 May;83(5):1519–1525. doi: 10.1161/01.cir.83.5.1519. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES